ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Neurotherapeutics Ltd

Neurotherapeutics Ltd is an active company incorporated on 12 February 2021 with the registered office located in Nottingham, Nottinghamshire. Neurotherapeutics Ltd was registered 4 years ago.
Status
Active
Active since incorporation
Company No
13198315
Private limited company
Age
4 years
Incorporated 12 February 2021
Size
Micro
Turnover is under £1M
Under 10 employees
Confirmation
Submitted
Dated 10 February 2025 (6 months ago)
Next confirmation dated 10 February 2026
Due by 24 February 2026 (5 months remaining)
Last change occurred 6 months ago
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Total Exemption Full
Next accounts for period 31 December 2025
Due by 30 September 2026 (1 year remaining)
Contact
Address
The Ingenuity Centre University Of Nottingham Innovation Park
Triumph Road
Nottingham
NG7 2TU
England
Same address since incorporation
Telephone
Unreported
Email
Unreported
People
Officers
8
Shareholders
55
Controllers (PSC)
1
Director • Director • Managing Partner - Investment Firm • British • Lives in Scotland • Born in Dec 1977
Director • Management Consultant • American • Lives in United States • Born in Apr 1968
Director • Spanish • Lives in England • Born in Sep 1990
Director • Consultant • British • Lives in Jersey • Born in Dec 1975
Director • British • Lives in England • Born in Sep 1964
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Rhodes Technologies Limited
Ian Rhodes is a mutual person.
Active
Exmoor Pharma Concepts Limited
Ian Rhodes is a mutual person.
Active
37 Clinical Limited
Ian Rhodes is a mutual person.
Active
37C Limited
Ian Rhodes is a mutual person.
Active
Eos Syndicate Management Limited
Andrew Paul McNeill is a mutual person.
Active
Dxcover Limited
Andrew Paul McNeill is a mutual person.
Active
Cumulus Oncology Limited
Andrew Paul McNeill is a mutual person.
Active
Eos Advisory LLP
Andrew Paul McNeill is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2021–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
£2M
Increased by £1.83M (+1139%)
Turnover
Unreported
Same as previous period
Employees
9
Increased by 3 (+50%)
Total Assets
£2.3M
Increased by £1.91M (+491%)
Total Liabilities
-£104.26K
Decreased by £76.7K (-42%)
Net Assets
£2.2M
Increased by £1.99M (+953%)
Debt Ratio (%)
5%
Decreased by 41.9% (-90%)
Latest Activity
Full Accounts Submitted
1 Month Ago on 23 Jul 2025
Confirmation Submitted
6 Months Ago on 18 Feb 2025
Mr David John O'reilly Appointed
1 Year Ago on 1 Sep 2024
Mr Karl Moss Appointed
1 Year Ago on 1 Sep 2024
Full Accounts Submitted
1 Year 3 Months Ago on 16 May 2024
Confirmation Submitted
1 Year 6 Months Ago on 8 Mar 2024
Stephen Raymond Jackson Resigned
1 Year 6 Months Ago on 28 Feb 2024
James Stuart Duncan Resigned
1 Year 6 Months Ago on 21 Feb 2024
Andrew Mcneill Appointed
1 Year 7 Months Ago on 8 Feb 2024
Full Accounts Submitted
2 Years 3 Months Ago on 7 Jun 2023
Get Credit Report
Discover Neurotherapeutics Ltd's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Total exemption full accounts made up to 31 December 2024
Submitted on 23 Jul 2025
Statement of capital following an allotment of shares on 16 May 2025
Submitted on 22 May 2025
Confirmation statement made on 10 February 2025 with updates
Submitted on 18 Feb 2025
Statement of capital following an allotment of shares on 9 October 2024
Submitted on 7 Nov 2024
Appointment of Mr David John O'reilly as a director on 1 September 2024
Submitted on 1 Oct 2024
Appointment of Mr Karl Moss as a director on 1 September 2024
Submitted on 30 Sep 2024
Memorandum and Articles of Association
Submitted on 26 Jul 2024
Resolutions
Submitted on 26 Jul 2024
Statement of capital following an allotment of shares on 23 July 2024
Submitted on 24 Jul 2024
Second filing of a statement of capital following an allotment of shares on 21 March 2024
Submitted on 16 Jul 2024
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year